|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004147,
umls-concept:C0023981,
umls-concept:C0032659,
umls-concept:C0034656,
umls-concept:C0039070,
umls-concept:C0127400,
umls-concept:C0205250,
umls-concept:C0231220,
umls-concept:C0235828,
umls-concept:C0599724,
umls-concept:C1708528
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-2-16
|
|
pubmed:abstractText |
This study was designed to evaluate the efficacy of atenolol for the long-term management of patients with vasovagal syncope. The primary hypothesis was that atenolol is not superior to placebo for the treatment of vasovagal syncope.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
554-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11216978-Adolescent,
pubmed-meshheading:11216978-Adrenergic beta-Antagonists,
pubmed-meshheading:11216978-Adult,
pubmed-meshheading:11216978-Aged,
pubmed-meshheading:11216978-Atenolol,
pubmed-meshheading:11216978-Double-Blind Method,
pubmed-meshheading:11216978-Female,
pubmed-meshheading:11216978-Humans,
pubmed-meshheading:11216978-Male,
pubmed-meshheading:11216978-Middle Aged,
pubmed-meshheading:11216978-Prospective Studies,
pubmed-meshheading:11216978-Recurrence,
pubmed-meshheading:11216978-Syncope, Vasovagal,
pubmed-meshheading:11216978-Tilt-Table Test,
pubmed-meshheading:11216978-Treatment Failure
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
|
|
pubmed:affiliation |
Cardiology Department, Ramón y Cajal Hospital, Alcalá University, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
